These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6670059)

  • 1. Methadone plasma levels and persistent drug abuse in high dose maintenance patients.
    Tennant FS; Rawson RA; Cohen A; Tarver A; Clabough D
    Subst Alcohol Actions Misuse; 1983; 4(5):369-74. PubMed ID: 6670059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone plasma levels and persistent drug abuse in high dose maintenance patients.
    Tennant FS; Rawson RA; Cohen A; Tarver A; Clabough D
    NIDA Res Monogr; 1984 Mar; 49():262-8. PubMed ID: 6434970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocaine abuse in methadone maintenance patients is associated with low serum methadone concentrations.
    Tennant F; Shannon J
    J Addict Dis; 1995; 14(1):67-74. PubMed ID: 7632748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
    Laqueille X; Launay C; Dervaux A; Kanit M
    Encephale; 2009 Jun; 35(3):220-5. PubMed ID: 19540407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma levomethadone level and concomitant use of sedatives in a methadone test program].
    Staak M; Käferstein H; Schumacher B; Sticht G; Iffland R
    Blutalkohol; 1993 Jul; 30(4):232-9. PubMed ID: 8373561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid negative feedback in methadone-maintained former heroin addicts with ongoing cocaine dependence: dose-response to dexamethasone suppression.
    Aouizerate B; Ho A; Schluger JH; Perret G; Borg L; Le Moal M; Piazza PV; Kreek MJ
    Addict Biol; 2006 Mar; 11(1):84-96. PubMed ID: 16759341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment.
    Pérez de los Cobos J; Siñol N; Trujols J; del Río E; Bañuls E; Luquero E; Menoyo A; Queraltó JM; Baiget M; Alvarez E
    Drug Alcohol Depend; 2007 Jul; 89(2-3):190-4. PubMed ID: 17234366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered methadone pharmacokinetics in pregnancy: implications for dosing.
    Swift RM; Dudley M; DePetrillo P; Camara P; Griffiths W
    J Subst Abuse; 1989; 1(4):453-60. PubMed ID: 2485290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of methadone in maintenance clients who persist in illicit drug use.
    Bell J; Bowron P; Lewis J; Batey R
    Br J Addict; 1990 Dec; 85(12):1599-602. PubMed ID: 1981155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study.
    Peles E; Bodner G; Kreek MJ; Rados V; Adelson M
    Addiction; 2007 Feb; 102(2):289-300. PubMed ID: 17222284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-prescribed drug use during methadone treatment by clinic- and community-based patients.
    Wolff K; Hay AW; Vail A; Harrison K; Raistrick D
    Addiction; 1996 Nov; 91(11):1699-704. PubMed ID: 8972927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain perception of intravenous heroin users on maintenance therapy with levomethadone.
    Schall U; Katta T; Pries E; Klöppel A; Gastpar M
    Pharmacopsychiatry; 1996 Sep; 29(5):176-9. PubMed ID: 8895942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of plasma and urine methadone concentrations to optimize treatment in maintenance clinics: I. Measurement techniques for a clinical setting.
    Kell MJ
    J Addict Dis; 1994; 13(1):5-26. PubMed ID: 8018740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone plasma levels in maintenance patients: the effect of dose omission.
    Verebely K; Kutt H
    Res Commun Chem Pathol Pharmacol; 1975 Jul; 11(3):373-86. PubMed ID: 1153882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues.
    Langleben DD; Ruparel K; Elman I; Busch-Winokur S; Pratiwadi R; Loughead J; O'Brien CP; Childress AR
    Am J Psychiatry; 2008 Mar; 165(3):390-4. PubMed ID: 18056224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.